| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ADRA1A HTR1D GPR18 ADGRG2 OR51I1 OR10AD1 SCN7A MC3R NTSR2 TAAR2 GPR183 GRPR CHRNA2 CHRNA3 CD200R1 CXCR1 OPRD1 CXCR2 | 1.45e-08 | 1353 | 56 | 18 | GO:0004888 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.21e-08 | 109 | 56 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ABCA6 RNF213 SRPRA ABCC12 ATP13A3 ATP1A2 ATP1A3 DNAH6 ATP8B2 ABCA8 | 3.28e-08 | 441 | 56 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | ADRA1A HTR1D GPR18 ADGRG2 OR51I1 OR10AD1 MC3R NTSR2 TAAR2 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 1.03e-07 | 884 | 56 | 14 | GO:0004930 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ABCA6 SLC27A6 RNF213 SRPRA ABCC12 ATP13A3 ATP1A2 ATP1A3 DNAH6 ATP8B2 ABCA8 | 1.04e-07 | 614 | 56 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.51e-07 | 49 | 56 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 6.38e-07 | 178 | 56 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 ABCA6 RNF213 SRPRA ABCC12 ATP13A3 GNAT1 ATP1A2 ATP1A3 DNAH6 ATP8B2 ABCA8 | 1.24e-06 | 775 | 56 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 ABCA6 RNF213 SRPRA ABCC12 ATP13A3 GNAT1 ATP1A2 ATP1A3 DNAH6 ATP8B2 ABCA8 | 2.84e-06 | 839 | 56 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 ABCA6 RNF213 SRPRA ABCC12 ATP13A3 GNAT1 ATP1A2 ATP1A3 DNAH6 ATP8B2 ABCA8 | 2.87e-06 | 840 | 56 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 ABCA6 RNF213 SRPRA ABCC12 ATP13A3 GNAT1 ATP1A2 ATP1A3 DNAH6 ATP8B2 ABCA8 | 2.87e-06 | 840 | 56 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | interleukin-8 receptor activity | 7.73e-06 | 2 | 56 | 2 | GO:0004918 | |
| GeneOntologyMolecularFunction | transporter activity | ABCC3 ABCA6 SLC27A6 TRPC4 SCN7A TMEM184C ABCC12 ATP13A3 ATP1A2 ATP1A3 ATP8B2 CHRNA2 ABCA8 CHRNA3 | 9.09e-06 | 1289 | 56 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | interleukin-8 binding | 2.31e-05 | 3 | 56 | 2 | GO:0019959 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC3 ABCA6 SLC27A6 TRPC4 SCN7A ABCC12 ATP13A3 ATP1A2 ATP1A3 CHRNA2 ABCA8 CHRNA3 | 8.49e-05 | 1180 | 56 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.40e-04 | 36 | 56 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.40e-04 | 36 | 56 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.52e-04 | 37 | 56 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | C-X-C chemokine binding | 1.61e-04 | 7 | 56 | 2 | GO:0019958 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 1.61e-04 | 7 | 56 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 2.07e-04 | 41 | 56 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | C-X-C chemokine receptor activity | 2.14e-04 | 8 | 56 | 2 | GO:0016494 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.20e-04 | 196 | 56 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 3.43e-04 | 10 | 56 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 3.43e-04 | 10 | 56 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 3.58e-04 | 477 | 56 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 4.18e-04 | 11 | 56 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.28e-04 | 133 | 56 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | steroid binding | 5.28e-04 | 133 | 56 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 6.41e-04 | 140 | 56 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 7.03e-04 | 62 | 56 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 7.92e-04 | 15 | 56 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.02e-03 | 17 | 56 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | protein binding involved in heterotypic cell-cell adhesion | 1.15e-03 | 18 | 56 | 2 | GO:0086080 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.88e-03 | 23 | 56 | 2 | GO:0015464 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 1.88e-03 | 23 | 56 | 2 | GO:0016493 | |
| GeneOntologyMolecularFunction | antigen binding | 1.98e-03 | 190 | 56 | 4 | GO:0003823 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 2.05e-03 | 24 | 56 | 2 | GO:0019957 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 2.40e-03 | 26 | 56 | 2 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 2.40e-03 | 26 | 56 | 2 | GO:0004950 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.46e-03 | 664 | 56 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 2.79e-03 | 28 | 56 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.79e-03 | 100 | 56 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | hormone binding | 3.03e-03 | 103 | 56 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | chemokine binding | 3.86e-03 | 33 | 56 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 4.09e-03 | 34 | 56 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 6.48e-03 | 793 | 56 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 6.48e-03 | 43 | 56 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 9.71e-03 | 53 | 56 | 2 | GO:0008188 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.11e-02 | 165 | 56 | 3 | GO:0140375 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.12e-02 | 57 | 56 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | peptide binding | 1.21e-02 | 318 | 56 | 4 | GO:0042277 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.23e-02 | 171 | 56 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.23e-02 | 60 | 56 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 1.27e-02 | 61 | 56 | 2 | GO:0098632 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.44e-02 | 65 | 56 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.44e-02 | 65 | 56 | 2 | GO:0022824 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 7.05e-08 | 133 | 56 | 7 | GO:0007200 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ADRA1A HTR1D GPR18 ADGRG2 OR51I1 OR10AD1 MC3R NTSR2 TAAR2 SYP C5 GPR183 GNAT1 GRPR CXCR1 OPRD1 CXCR2 | 9.19e-08 | 1395 | 56 | 17 | GO:0007186 |
| GeneOntologyBiologicalProcess | interleukin-8-mediated signaling pathway | 7.24e-06 | 2 | 56 | 2 | GO:0038112 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 1.11e-05 | 51 | 56 | 4 | GO:0055078 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.80e-05 | 559 | 56 | 9 | GO:0042391 | |
| GeneOntologyBiologicalProcess | response to nicotine | 1.85e-05 | 58 | 56 | 4 | GO:0035094 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-8 | 2.17e-05 | 3 | 56 | 2 | GO:0098759 | |
| GeneOntologyBiologicalProcess | response to interleukin-8 | 2.17e-05 | 3 | 56 | 2 | GO:0098758 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 2.27e-05 | 61 | 56 | 4 | GO:0007187 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 2.69e-05 | 449 | 56 | 8 | GO:0050900 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 4.14e-05 | 235 | 56 | 6 | GO:0016064 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 5.10e-05 | 244 | 56 | 6 | GO:0019724 | |
| GeneOntologyBiologicalProcess | dendritic cell chemotaxis | 6.59e-05 | 29 | 56 | 3 | GO:0002407 | |
| GeneOntologyBiologicalProcess | mononuclear cell migration | 6.95e-05 | 258 | 56 | 6 | GO:0071674 | |
| GeneOntologyBiologicalProcess | response to glycoside | 7.20e-05 | 5 | 56 | 2 | GO:1903416 | |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 7.31e-05 | 30 | 56 | 3 | GO:0006883 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.22e-04 | 286 | 56 | 6 | GO:0007188 | |
| GeneOntologyBiologicalProcess | dendritic cell migration | 1.27e-04 | 36 | 56 | 3 | GO:0036336 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC3 ADRA1A TRPC4 SCN7A NDFIP2 ATP13A3 ATP1A2 ATP1A3 ATP8B2 CHRNA2 CHRNA3 OPRD1 | 2.62e-04 | 1374 | 56 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.27e-04 | 121 | 56 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 3.92e-04 | 11 | 56 | 2 | GO:0010248 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 4.68e-04 | 133 | 56 | 4 | GO:0006939 | |
| GeneOntologyBiologicalProcess | immune effector process | IGHV3-38 IGHV3-16 IGHV3-11 CD37 CD47 C5 GPR183 TP53BP1 IGHV3-64 | 4.71e-04 | 859 | 56 | 9 | GO:0002252 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte migration | 5.53e-04 | 59 | 56 | 3 | GO:0002686 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 5.54e-04 | 13 | 56 | 2 | GO:0038003 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 5.83e-04 | 141 | 56 | 4 | GO:0051588 | |
| GeneOntologyBiologicalProcess | behavior | 6.14e-04 | 891 | 56 | 9 | GO:0007610 | |
| GeneOntologyBiologicalProcess | muscle contraction | 7.34e-04 | 400 | 56 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC3 ADRA1A TRPC4 SCN7A ATP13A3 ATP1A2 ATP1A3 ATP8B2 CHRNA2 CHRNA3 | 7.51e-04 | 1115 | 56 | 10 | GO:0034220 |
| GeneOntologyBiologicalProcess | fear response | 7.68e-04 | 66 | 56 | 3 | GO:0042596 | |
| GeneOntologyBiologicalProcess | circulatory system process | 7.69e-04 | 733 | 56 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte migration | 7.80e-04 | 267 | 56 | 5 | GO:0002685 | |
| GeneOntologyBiologicalProcess | leukocyte chemotaxis | 7.80e-04 | 267 | 56 | 5 | GO:0030595 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid metabolic process | 8.48e-04 | 16 | 56 | 2 | GO:0019852 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage migration | 8.48e-04 | 16 | 56 | 2 | GO:1905522 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte migration | 9.05e-04 | 276 | 56 | 5 | GO:0097529 | |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 9.59e-04 | 17 | 56 | 2 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 9.59e-04 | 17 | 56 | 2 | GO:0036376 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 1.03e-03 | 284 | 56 | 5 | GO:0007626 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 1.10e-03 | 167 | 56 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 1.20e-03 | 19 | 56 | 2 | GO:0006855 | |
| GeneOntologyBiologicalProcess | lactone metabolic process | 1.20e-03 | 19 | 56 | 2 | GO:1901334 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.27e-03 | 298 | 56 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 1.30e-03 | 79 | 56 | 3 | GO:0006940 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 1.33e-03 | 449 | 56 | 6 | GO:0002449 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 1.41e-03 | 622 | 56 | 7 | GO:0098771 | |
| GeneOntologyBiologicalProcess | response to potassium ion | 1.47e-03 | 21 | 56 | 2 | GO:0035864 | |
| GeneOntologyBiologicalProcess | heart process | 1.49e-03 | 309 | 56 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.54e-03 | 462 | 56 | 6 | GO:0002460 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 1.62e-03 | 22 | 56 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | visual behavior | 1.65e-03 | 86 | 56 | 3 | GO:0007632 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte chemotaxis | 1.77e-03 | 23 | 56 | 2 | GO:0002689 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.78e-03 | 648 | 56 | 7 | GO:0008015 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.80e-03 | 191 | 56 | 4 | GO:0007189 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.52e-04 | 583 | 56 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | distal axon | 1.55e-04 | 435 | 56 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 4.57e-04 | 12 | 56 | 2 | GO:0005890 | |
| GeneOntologyCellularComponent | transporter complex | 6.38e-04 | 550 | 56 | 7 | GO:1990351 | |
| GeneOntologyCellularComponent | plasma membrane raft | 6.49e-04 | 147 | 56 | 4 | GO:0044853 | |
| GeneOntologyCellularComponent | cell surface | ADGRG2 TRPC4 CD47 NTSR2 ITGA3 ATP1A2 ATP1A3 CD200R1 CXCR1 CXCR2 | 6.59e-04 | 1111 | 56 | 10 | GO:0009986 |
| GeneOntologyCellularComponent | postsynaptic membrane | 7.30e-04 | 405 | 56 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | presynaptic membrane | 8.67e-04 | 277 | 56 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 1.02e-03 | 166 | 56 | 4 | GO:0019814 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 1.05e-03 | 18 | 56 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.10e-03 | 785 | 56 | 8 | GO:0098797 | |
| GeneOntologyCellularComponent | postsynapse | 1.43e-03 | 1018 | 56 | 9 | GO:0098794 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 1.57e-03 | 22 | 56 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | sarcolemma | 1.68e-03 | 190 | 56 | 4 | GO:0042383 | |
| GeneOntologyCellularComponent | axon terminus | 2.42e-03 | 210 | 56 | 4 | GO:0043679 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.68e-03 | 523 | 56 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | caveola | 3.29e-03 | 111 | 56 | 3 | GO:0005901 | |
| GeneOntologyCellularComponent | neuron projection terminus | 3.51e-03 | 233 | 56 | 4 | GO:0044306 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 4.19e-03 | 36 | 56 | 2 | GO:0098992 | |
| GeneOntologyCellularComponent | growth cone | 4.20e-03 | 245 | 56 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | neuron spine | 4.32e-03 | 247 | 56 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | site of polarized growth | 4.70e-03 | 253 | 56 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 5.04e-03 | 1228 | 56 | 9 | GO:0036477 | |
| HumanPheno | Episodic quadriplegia | 8.09e-06 | 2 | 15 | 2 | HP:0200072 | |
| HumanPheno | Episodic hemiplegia | 4.84e-05 | 4 | 15 | 2 | HP:0012194 | |
| HumanPheno | Skewfoot | 1.21e-04 | 6 | 15 | 2 | HP:0032649 | |
| HumanPheno | Ocular flutter | 1.21e-04 | 6 | 15 | 2 | HP:0031931 | |
| Domain | 7TM_GPCR_Srsx | 7.84e-10 | 112 | 52 | 8 | SM01381 | |
| Domain | GPCR_Rhodpsn_7TM | ADRA1A HTR1D GPR18 OR51I1 OR10AD1 MC3R NTSR2 TAAR2 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 2.54e-08 | 670 | 52 | 13 | IPR017452 |
| Domain | 7tm_1 | ADRA1A HTR1D GPR18 OR51I1 OR10AD1 MC3R NTSR2 TAAR2 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 2.87e-08 | 677 | 52 | 13 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | ADRA1A HTR1D GPR18 OR51I1 OR10AD1 MC3R NTSR2 TAAR2 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 3.29e-08 | 685 | 52 | 13 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | ADRA1A HTR1D GPR18 OR51I1 OR10AD1 MC3R NTSR2 TAAR2 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 3.65e-08 | 691 | 52 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | ADRA1A HTR1D GPR18 OR51I1 OR10AD1 MC3R NTSR2 TAAR2 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 3.71e-08 | 692 | 52 | 13 | IPR000276 |
| Domain | AAA+_ATPase | 1.40e-07 | 144 | 52 | 7 | IPR003593 | |
| Domain | AAA | 1.40e-07 | 144 | 52 | 7 | SM00382 | |
| Domain | - | 1.81e-06 | 32 | 52 | 4 | 2.70.150.10 | |
| Domain | - | 1.81e-06 | 32 | 52 | 4 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 2.62e-06 | 35 | 52 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 2.95e-06 | 36 | 52 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 2.95e-06 | 36 | 52 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.95e-06 | 36 | 52 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.30e-06 | 37 | 52 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.30e-06 | 37 | 52 | 4 | PF00122 | |
| Domain | Chemokine_CXCR_1/2 | 7.60e-06 | 2 | 52 | 2 | IPR000174 | |
| Domain | ABC_TRANSPORTER_2 | 9.49e-06 | 48 | 52 | 4 | PS50893 | |
| Domain | ABC_tran | 9.49e-06 | 48 | 52 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 1.03e-05 | 49 | 52 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.12e-05 | 50 | 52 | 4 | IPR003439 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.35e-05 | 17 | 52 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.35e-05 | 17 | 52 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 1.61e-05 | 18 | 52 | 3 | PF00690 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.91e-05 | 19 | 52 | 3 | IPR004014 | |
| Domain | HAD-like_dom | 6.88e-05 | 79 | 52 | 4 | IPR023214 | |
| Domain | P-type_ATPase_IIC | 1.13e-04 | 6 | 52 | 2 | IPR005775 | |
| Domain | CXCR4/ACKR2 | 1.58e-04 | 7 | 52 | 2 | IPR001277 | |
| Domain | ABC_A | 4.93e-04 | 12 | 52 | 2 | IPR026082 | |
| Domain | - | 8.90e-04 | 16 | 52 | 2 | 1.20.1110.10 | |
| Domain | Nicotinic_acetylcholine_rcpt | 8.90e-04 | 16 | 52 | 2 | IPR002394 | |
| Domain | ATPase_P-typ_TM_dom | 8.90e-04 | 16 | 52 | 2 | IPR023298 | |
| Domain | - | 9.90e-04 | 746 | 52 | 8 | 3.40.50.300 | |
| Domain | Cation_ATPase_N | 1.13e-03 | 18 | 52 | 2 | SM00831 | |
| Domain | Acetylcholine_rcpt_TM | 1.85e-03 | 23 | 52 | 2 | IPR027361 | |
| Domain | - | 1.85e-03 | 23 | 52 | 2 | 1.20.120.370 | |
| Domain | ABC_membrane | 2.02e-03 | 24 | 52 | 2 | PF00664 | |
| Domain | P-loop_NTPase | 2.23e-03 | 848 | 52 | 8 | IPR027417 | |
| Domain | ABC_TM1F | 2.74e-03 | 28 | 52 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 2.74e-03 | 28 | 52 | 2 | IPR011527 | |
| Domain | ABC_transporter_CS | 6.10e-03 | 42 | 52 | 2 | IPR017871 | |
| Domain | Neurotransmitter_ion_chnl_CS | 6.97e-03 | 45 | 52 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 7.28e-03 | 46 | 52 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 7.59e-03 | 47 | 52 | 2 | PF02931 | |
| Domain | Neur_channel | 7.59e-03 | 47 | 52 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 7.59e-03 | 47 | 52 | 2 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 7.59e-03 | 47 | 52 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 7.59e-03 | 47 | 52 | 2 | IPR006029 | |
| Domain | - | 7.59e-03 | 47 | 52 | 2 | 2.70.170.10 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | ADRA1A HTR1D GPR18 MC3R NTSR2 TAAR2 C5 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 2.39e-10 | 330 | 44 | 12 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | ADRA1A HTR1D GPR18 MC3R NTSR2 TAAR2 C5 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 2.65e-10 | 333 | 44 | 12 | MM14963 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | ADRA1A HTR1D GPR18 MC3R NTSR2 TAAR2 C5 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 4.85e-09 | 430 | 44 | 12 | MM15160 |
| Pathway | WP_GPCRS_NONODORANT | 6.82e-09 | 266 | 44 | 10 | MM15843 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | ADRA1A HTR1D GPR18 MC3R NTSR2 TAAR2 C5 GPR183 GRPR CXCR1 OPRD1 CXCR2 | 1.11e-08 | 463 | 44 | 12 | M507 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ADRA1A HTR1D GPR18 MC3R NTSR2 TAAR2 C5 GPR183 GNAT1 GRPR CXCR1 OPRD1 CXCR2 | 4.86e-08 | 646 | 44 | 13 | MM14962 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 8.67e-08 | 260 | 44 | 9 | M39397 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.11e-07 | 75 | 44 | 6 | M39696 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.28e-07 | 272 | 44 | 9 | M13380 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ADRA1A HTR1D GPR18 MC3R NTSR2 TAAR2 C5 GPR183 GNAT1 GRPR CXCR1 OPRD1 CXCR2 | 1.28e-07 | 702 | 44 | 13 | M746 |
| Pathway | WP_GPCRS_OTHER | 4.04e-07 | 93 | 44 | 6 | M39629 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.58e-06 | 186 | 44 | 7 | MM15994 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 2.31e-06 | 197 | 44 | 7 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 2.31e-06 | 197 | 44 | 7 | MM14970 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.44e-06 | 70 | 44 | 5 | MM15959 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 2.64e-06 | 289 | 44 | 8 | MM15057 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.89e-06 | 314 | 44 | 8 | M600 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.02e-05 | 44 | 44 | 4 | M11911 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 2.99e-04 | 42 | 44 | 3 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 2.99e-04 | 42 | 44 | 3 | MM14971 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.38e-04 | 9 | 44 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.38e-04 | 9 | 44 | 2 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 5.14e-04 | 11 | 44 | 2 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 6.16e-04 | 12 | 44 | 2 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 6.16e-04 | 12 | 44 | 2 | MM15312 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 6.65e-04 | 55 | 44 | 3 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.38e-04 | 57 | 44 | 3 | MM15643 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 8.46e-04 | 14 | 44 | 2 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 9.74e-04 | 15 | 44 | 2 | MM14704 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.08e-03 | 681 | 44 | 8 | MM14985 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.45e-03 | 158 | 44 | 4 | MM14812 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.77e-03 | 736 | 44 | 8 | M27287 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.16e-03 | 176 | 44 | 4 | MM15718 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.27e-03 | 84 | 44 | 3 | MM14653 | |
| Pathway | KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION | 2.31e-03 | 23 | 44 | 2 | M4361 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.49e-03 | 183 | 44 | 4 | M997 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.61e-03 | 99 | 44 | 3 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 4.04e-03 | 103 | 44 | 3 | M758 | |
| Pathway | WP_MONOAMINE_GPCRS | 4.18e-03 | 31 | 44 | 2 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 4.73e-03 | 33 | 44 | 2 | M39585 | |
| Pubmed | 3.44e-11 | 200 | 56 | 9 | 18240029 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 15946947 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 12458206 | ||
| Pubmed | 4.48e-07 | 179 | 56 | 6 | 18577758 | ||
| Pubmed | 4.75e-07 | 39 | 56 | 4 | 8490662 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21555225 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19585580 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21254176 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18307412 | ||
| Pubmed | Attenuation of murine allergic airway inflammation with a CXCR1/CXCR2 chemokine receptor inhibitor. | 2.55e-06 | 2 | 56 | 2 | 30218547 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26302999 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21915051 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18668539 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16987681 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22076427 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12442335 | ||
| Pubmed | Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer. | 2.55e-06 | 2 | 56 | 2 | 22371491 | |
| Pubmed | Roles of mechanical force and CXCR1/CXCR2 in shear-stress-induced endothelial cell migration. | 2.55e-06 | 2 | 56 | 2 | 21989491 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 30341468 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 7929358 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21036625 | ||
| Pubmed | ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. | 2.55e-06 | 2 | 56 | 2 | 33880529 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 20082763 | ||
| Pubmed | The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. | 2.55e-06 | 2 | 56 | 2 | 20044480 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26791948 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11397869 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15618253 | ||
| Pubmed | The structure of the Na+,K+-ATPase and mapping of isoform differences and disease-related mutations. | 2.55e-06 | 2 | 56 | 2 | 18957371 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17996233 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15028716 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12740597 | ||
| Pubmed | CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. | 2.55e-06 | 2 | 56 | 2 | 19401689 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15772681 | ||
| Pubmed | A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients. | 2.55e-06 | 2 | 56 | 2 | 17360650 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22171941 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 27974825 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 29577511 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8384312 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25022956 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 28472154 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16806108 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 7829970 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26087179 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22152684 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 34730557 | ||
| Pubmed | Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2. | 2.55e-06 | 2 | 56 | 2 | 12239185 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 20016196 | ||
| Pubmed | Expression of CXC receptor 1 and 2 in esophageal mucosa of patients with reflux esophagitis. | 2.55e-06 | 2 | 56 | 2 | 15793866 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15265017 | ||
| Pubmed | CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease. | 2.55e-06 | 2 | 56 | 2 | 22088968 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 26847910 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 24356962 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 14713106 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19230171 | ||
| Pubmed | Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes. | 2.55e-06 | 2 | 56 | 2 | 27551720 | |
| Pubmed | [The role of CXCR1/2 in shear stress-induced endothelial cell migration]. | 2.55e-06 | 2 | 56 | 2 | 19634663 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 6.66e-06 | 1061 | 56 | 10 | 33845483 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 2822726 | ||
| Pubmed | Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes. | 7.63e-06 | 3 | 56 | 2 | 30819023 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 17295203 | ||
| Pubmed | CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. | 7.63e-06 | 3 | 56 | 2 | 22996693 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 9843397 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 21749879 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 11196695 | ||
| Pubmed | Structure and functional expression of a human interleukin-8 receptor. | 7.63e-06 | 3 | 56 | 2 | 1840701 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 17204468 | ||
| Pubmed | Molecular evolution of the human interleukin-8 receptor gene cluster. | 7.63e-06 | 3 | 56 | 2 | 1303245 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 34050991 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 20630874 | ||
| Pubmed | Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. | 7.63e-06 | 3 | 56 | 2 | 19890050 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 16679868 | ||
| Pubmed | The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinoma. | 7.63e-06 | 3 | 56 | 2 | 22626766 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 8195702 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 17947306 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 23912333 | ||
| Pubmed | Characterization of two high affinity human interleukin-8 receptors. | 7.63e-06 | 3 | 56 | 2 | 1379593 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 36086981 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 24946112 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 19058785 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 28465228 | ||
| Pubmed | The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. | 7.63e-06 | 3 | 56 | 2 | 24678812 | |
| Pubmed | EBI2, GPR18 and GPR17--three structurally related, but biologically distinct 7TM receptors. | 7.63e-06 | 3 | 56 | 2 | 21261596 | |
| Pubmed | Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. | 7.63e-06 | 3 | 56 | 2 | 12870115 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 19118103 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 33544780 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 8203495 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 24161763 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 29749433 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 31613654 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 15598788 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 11007922 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18044013 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 26267317 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 22482416 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 31666007 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 20089160 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 22242662 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 19151925 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 27578214 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 24462138 | ||
| Interaction | CXCR2 interactions | 2.02e-06 | 36 | 51 | 4 | int:CXCR2 | |
| Interaction | OPALIN interactions | 1.41e-05 | 209 | 51 | 6 | int:OPALIN | |
| Interaction | GNA14 interactions | 1.97e-05 | 21 | 51 | 3 | int:GNA14 | |
| Interaction | CXCR1 interactions | 1.97e-05 | 21 | 51 | 3 | int:CXCR1 | |
| Interaction | EMP1 interactions | 2.20e-05 | 65 | 51 | 4 | int:EMP1 | |
| Interaction | GNA15 interactions | 3.81e-05 | 26 | 51 | 3 | int:GNA15 | |
| Interaction | ARL5B interactions | 4.75e-05 | 79 | 51 | 4 | int:ARL5B | |
| Interaction | TYROBP interactions | 7.25e-05 | 88 | 51 | 4 | int:TYROBP | |
| Interaction | F2R interactions | 9.44e-05 | 35 | 51 | 3 | int:F2R | |
| Interaction | ADRA1A interactions | 1.12e-04 | 37 | 51 | 3 | int:ADRA1A | |
| Interaction | KLRD1 interactions | 1.39e-04 | 104 | 51 | 4 | int:KLRD1 | |
| Interaction | HCST interactions | 1.67e-04 | 205 | 51 | 5 | int:HCST | |
| Interaction | ABCA8 interactions | 2.23e-04 | 9 | 51 | 2 | int:ABCA8 | |
| Interaction | CD37 interactions | 2.23e-04 | 9 | 51 | 2 | int:CD37 | |
| Interaction | ZDHHC9 interactions | 2.59e-04 | 49 | 51 | 3 | int:ZDHHC9 | |
| Interaction | TPST2 interactions | 2.73e-04 | 124 | 51 | 4 | int:TPST2 | |
| Interaction | ABCA6 interactions | 2.79e-04 | 10 | 51 | 2 | int:ABCA6 | |
| Cytoband | Xp11.23-p11.22 | 3.06e-05 | 7 | 56 | 2 | Xp11.23-p11.22 | |
| Cytoband | 14q32.33 | 1.78e-04 | 228 | 56 | 4 | 14q32.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q32 | 2.27e-04 | 96 | 56 | 3 | chr13q32 | |
| Cytoband | 13q32.3 | 3.64e-04 | 23 | 56 | 2 | 13q32.3 | |
| Cytoband | 2q35 | 4.24e-03 | 79 | 56 | 2 | 2q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 5.06e-03 | 566 | 56 | 4 | chr14q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 6.44e-03 | 98 | 56 | 2 | chr17q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 1.09e-02 | 129 | 56 | 2 | chr2q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 1.19e-02 | 135 | 56 | 2 | chr8p21 | |
| GeneFamily | CD molecules|C-X-C motif chemokine receptors | 8.63e-05 | 6 | 44 | 2 | 1094 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.21e-04 | 7 | 44 | 2 | 1208 | |
| GeneFamily | ATP binding cassette subfamily C | 4.44e-04 | 13 | 44 | 2 | 807 | |
| GeneFamily | ATP binding cassette subfamily A | 5.17e-04 | 14 | 44 | 2 | 805 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 6.80e-04 | 16 | 44 | 2 | 173 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | 1.09e-03 | 187 | 44 | 4 | 349 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.59e-03 | 394 | 44 | 5 | 471 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 4.68e-03 | 42 | 44 | 2 | 602 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.55e-02 | 78 | 44 | 2 | 262 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 4.22e-05 | 84 | 49 | 4 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 5.25e-05 | 427 | 49 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_500 | 5.77e-05 | 91 | 49 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_200 | 7.18e-05 | 35 | 49 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200_k1 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.13e-07 | 140 | 56 | 5 | 8db98a17a4d4b42dbfc75e9cdaa22275fed4f2f0 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia.C1qb.Tmem119-Fos)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.13e-07 | 140 | 56 | 5 | 22098203361f61b9f0ce9f0f2d1369d8bb1379a8 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.13e-07 | 140 | 56 | 5 | 2c04fa782aa076e4be8a2781aa04231180bd69bd | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia.C1qb.Tmem119-Fos)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.13e-07 | 140 | 56 | 5 | a9389a6e55d02d5037868c9ecce48b5e8d7c2902 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.24e-06 | 149 | 56 | 5 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.24e-06 | 149 | 56 | 5 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 155 | 56 | 5 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.51e-06 | 155 | 56 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-06 | 162 | 56 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-06 | 173 | 56 | 5 | 8ca650542655c27516029e5bace97ff1b9dcc256 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-06 | 173 | 56 | 5 | 4282b47b33325472f52a4085986988911a372ed8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-06 | 174 | 56 | 5 | cc4c7f00a25a7814b52d4599166615daa140cc31 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-06 | 174 | 56 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-06 | 180 | 56 | 5 | 7d3d5608647b6e684e8e185993d106a38c53e76a | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.14e-06 | 180 | 56 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-06 | 183 | 56 | 5 | 3ebe334ad570e3525341badb558f369c61daf3d3 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.78e-06 | 187 | 56 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 189 | 56 | 5 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 189 | 56 | 5 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-06 | 190 | 56 | 5 | bdbfaced785db79ff965f332759be258dbf743cf | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.41e-06 | 193 | 56 | 5 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-06 | 193 | 56 | 5 | 8851275bcf4ecd6e87a91c8784fc5d76d246ff3b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.41e-06 | 193 | 56 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.41e-06 | 193 | 56 | 5 | 7b4b0271e4fbece703876acb053ae236afb7cdba | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 4.64e-06 | 195 | 56 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.64e-06 | 195 | 56 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-06 | 195 | 56 | 5 | b25c534fc6320d4da6437ef1b27e32a5d5256f3e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.87e-06 | 197 | 56 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.00e-06 | 198 | 56 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-dn_T|IIF / Disease, condition lineage and cell class | 5.25e-06 | 200 | 56 | 5 | c34fff02992cba6bcc2308019cb00b94e1227300 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-05 | 125 | 56 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.11e-05 | 129 | 56 | 4 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 130 | 56 | 4 | 4c8b931987432e8bcd39029d4fa124dc383ea355 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.52e-05 | 135 | 56 | 4 | 451e90c154e26ae4f72269d6765e7ef51d67313a | |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma-Plasma_cells|blood / Manually curated celltypes from each tissue | 3.52e-05 | 147 | 56 | 4 | 58089378fac1743ce99dc4f1bd7b5253a927f050 | |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma|blood / Manually curated celltypes from each tissue | 3.81e-05 | 150 | 56 | 4 | 6bab0a8bf78ed7de9e1b67ede7496488f80f4863 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.01e-05 | 152 | 56 | 4 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.33e-05 | 155 | 56 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | Striatum-Hematopoietic|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.33e-05 | 155 | 56 | 4 | 12301d823338bf829475905c66c5f08f7159d29f | |
| ToppCell | Globus_pallidus-Hematopoietic|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.44e-05 | 156 | 56 | 4 | 67cdaadc3b917f7072adce16c0391472c14a2563 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 157 | 56 | 4 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 157 | 56 | 4 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 157 | 56 | 4 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 158 | 56 | 4 | 98fd640ef0bd0014b8c38b81bd5160efcf42f23c | |
| ToppCell | droplet-Heart-nan-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 158 | 56 | 4 | 81a5a73090804d41429d297ba2462a842f39d380 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 158 | 56 | 4 | 9596b7b0f6f5157a43d67d2e67fb75a2624a6bb9 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 158 | 56 | 4 | 7ebc8b778c97c0faa79e2d80c98b887fa635f901 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 158 | 56 | 4 | 4d2d69fbb880b5232d7867b4d099d0f047ca9ebe | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.78e-05 | 159 | 56 | 4 | 41d2c1e71f6983156f8cc8ec5f69e025e5700f46 | |
| ToppCell | Frontal_cortex-Hematopoietic|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.90e-05 | 160 | 56 | 4 | 70ffbe61cfd729519b23569a43d929b117ab8d5e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.02e-05 | 161 | 56 | 4 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 161 | 56 | 4 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 161 | 56 | 4 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | 6d8b5669eee9b0903c9260fea707d186c9d7fefa | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | 02cd87dfa2ca40e13455a4b9308477e82f76289b | |
| ToppCell | Thalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.65e-05 | 166 | 56 | 4 | 76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.65e-05 | 166 | 56 | 4 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.92e-05 | 168 | 56 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.06e-05 | 169 | 56 | 4 | dc388f660f69e37e517bf3243daf071ab138ee6e | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.06e-05 | 169 | 56 | 4 | 41cb92b0558f0d5a3e511058efd9110258b88ee3 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.06e-05 | 169 | 56 | 4 | 91f4b6a14708e701b2af22989004282041777491 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 6.06e-05 | 169 | 56 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 6.20e-05 | 170 | 56 | 4 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-05 | 170 | 56 | 4 | 667443062882642211ad116043775ef8eda38859 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-05 | 172 | 56 | 4 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.49e-05 | 172 | 56 | 4 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-05 | 172 | 56 | 4 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-05 | 172 | 56 | 4 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-05 | 172 | 56 | 4 | 07620728a6cdeea805e1365e588be096c17a370c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-05 | 173 | 56 | 4 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.63e-05 | 173 | 56 | 4 | 120dd20e8a71f9169a1596b6171df7aa0b96dd15 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-3_PAX6_NABP1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-05 | 173 | 56 | 4 | 0d38206e25434386b1aec2078067efc67b496c10 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.63e-05 | 173 | 56 | 4 | b2c55084ef6dac0e329c2e65c24cfe0045859c30 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.63e-05 | 173 | 56 | 4 | 2cba41c3d9d3076f703115d19729073a3ac3feb6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.63e-05 | 173 | 56 | 4 | 11d69a4ab4a87b8820cd3bd204de8c4124450a90 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-05 | 174 | 56 | 4 | c9d4e375dedd2b099a9ed70ec38ff35bbb0ce48a | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.78e-05 | 174 | 56 | 4 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.78e-05 | 174 | 56 | 4 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-05 | 174 | 56 | 4 | 1463c98f8f519dd030587abbdbeb1b4e1bca5dd1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-05 | 174 | 56 | 4 | d421c0069d24cb560a3a429929e3cd1eceaeabcf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.78e-05 | 174 | 56 | 4 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.78e-05 | 174 | 56 | 4 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.78e-05 | 174 | 56 | 4 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | facs-BAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 175 | 56 | 4 | 46d6e319f8ca46592f23257800bcb6d228fffbbe | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.94e-05 | 175 | 56 | 4 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-05 | 175 | 56 | 4 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.94e-05 | 175 | 56 | 4 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 175 | 56 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.94e-05 | 175 | 56 | 4 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-05 | 176 | 56 | 4 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 176 | 56 | 4 | 0089b50d607f4d2f18639fab0f3fc779227baa7a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-05 | 176 | 56 | 4 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.25e-05 | 177 | 56 | 4 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-05 | 177 | 56 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-05 | 177 | 56 | 4 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.25e-05 | 177 | 56 | 4 | 8c6d8a1c469346e66f9095d86b4615f8fc611362 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-05 | 177 | 56 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| Computational | Genes in the cancer module 288. | 2.48e-04 | 37 | 36 | 3 | MODULE_288 | |
| Computational | Genes in the cancer module 412. | 8.31e-04 | 13 | 36 | 2 | MODULE_412 | |
| Computational | AcetylCholine receptors. | 9.68e-04 | 14 | 36 | 2 | MODULE_328 | |
| Computational | Genes in the cancer module 27. | 1.05e-03 | 355 | 36 | 6 | MODULE_27 | |
| Computational | Genes in the cancer module 267. | 1.11e-03 | 15 | 36 | 2 | MODULE_267 | |
| Computational | Genes in the cancer module 275. | 1.27e-03 | 16 | 36 | 2 | MODULE_275 | |
| Computational | Membranal receptors. | 1.41e-03 | 517 | 36 | 7 | MODULE_64 | |
| Drug | verapamil | ABCC3 ADRA1A ABCA6 SCN7A PCSK7 ABCC12 ATP1A2 ATP1A3 CHRNA2 ABCA8 CHRNA3 | 1.12e-08 | 490 | 52 | 11 | CID000002520 |
| Drug | tetradotoxin | ADRA1A HTR1D SCN7A NTSR2 SYP ATP1A2 ATP1A3 CHRNA2 CHRNA3 OPRD1 | 3.88e-08 | 428 | 52 | 10 | CID000020382 |
| Drug | deltorphin II, Ala(2)- | 4.49e-08 | 4 | 52 | 3 | ctd:C060209 | |
| Drug | neostigmine | 4.62e-08 | 87 | 52 | 6 | CID000004456 | |
| Drug | myo-inositol | ADRA1A GPR18 TRPC4 NTSR2 PCSK7 FLRT3 GPR183 GNAT1 GRPR CHRNA2 CHRNA3 OPRD1 | 2.14e-07 | 811 | 52 | 12 | CID000000892 |
| Drug | phentolamine | 3.48e-07 | 200 | 52 | 7 | CID000005775 | |
| Drug | (+/-)-Epibatidine | 1.20e-06 | 35 | 52 | 4 | CID000001204 | |
| Drug | acetylcholine | 1.51e-06 | 361 | 52 | 8 | CID000000187 | |
| Drug | NSC7524 | 3.60e-06 | 182 | 52 | 6 | CID000005657 | |
| Drug | 3-isoreserpine | 4.62e-06 | 190 | 52 | 6 | CID000005052 | |
| Drug | phenoxybenzamine | 6.48e-06 | 115 | 52 | 5 | CID000004768 | |
| Drug | Substance P | 1.24e-05 | 343 | 52 | 7 | CID000036511 | |
| Drug | Ultracet | 1.39e-05 | 64 | 52 | 4 | CID000005523 | |
| Drug | 4-DAMP | 1.48e-05 | 65 | 52 | 4 | CID000001734 | |
| Drug | diaminocyclobut-3-ene-1,2-dione | 1.53e-05 | 3 | 52 | 2 | CID002781329 | |
| Drug | 5-methoxysalicylaldehyde | 1.53e-05 | 3 | 52 | 2 | CID000095695 | |
| Drug | DTTA | 1.53e-05 | 3 | 52 | 2 | CID000166909 | |
| Drug | Ionophores | 1.53e-05 | 3 | 52 | 2 | ctd:D007476 | |
| Drug | dimethylcyclohexane | 1.53e-05 | 3 | 52 | 2 | CID000011549 | |
| Drug | benzilate | 1.57e-05 | 66 | 52 | 4 | CID000201538 | |
| Drug | AC1NSKJI | 1.77e-05 | 68 | 52 | 4 | CID005311391 | |
| Drug | hexamethonium | 1.87e-05 | 143 | 52 | 5 | CID000003604 | |
| Drug | CID6325740 | 1.93e-05 | 23 | 52 | 3 | CID006325740 | |
| Drug | Digocin | 1.98e-05 | 70 | 52 | 4 | CID000003062 | |
| Drug | Barium | 2.22e-05 | 72 | 52 | 4 | ctd:D001464 | |
| Drug | oriens | 2.67e-05 | 154 | 52 | 5 | CID000161645 | |
| Drug | endomorphin 2 | 3.06e-05 | 4 | 52 | 2 | ctd:C105294 | |
| Drug | nitroethylene | 3.06e-05 | 4 | 52 | 2 | CID000077197 | |
| Drug | AS701 | 3.06e-05 | 4 | 52 | 2 | CID000133528 | |
| Drug | methylcarbamylcholine | 3.16e-05 | 27 | 52 | 3 | CID000004136 | |
| Drug | oxymetazoline | 3.20e-05 | 79 | 52 | 4 | CID000004636 | |
| Drug | serotonin | 3.43e-05 | 554 | 52 | 8 | CID000005202 | |
| Drug | bupropion | 3.53e-05 | 81 | 52 | 4 | CID000000444 | |
| Drug | trimethaphan | 3.53e-05 | 81 | 52 | 4 | CID000023576 | |
| Drug | clozapine | 3.68e-05 | 274 | 52 | 6 | CID000002818 | |
| Drug | NSC755875 | 3.71e-05 | 165 | 52 | 5 | CID000002215 | |
| Drug | EN-1530 | 3.99e-05 | 278 | 52 | 6 | CID000004425 | |
| Drug | pseudococaine | 4.19e-05 | 570 | 52 | 8 | CID000002826 | |
| Drug | brimonidine | 4.47e-05 | 86 | 52 | 4 | CID000002435 | |
| Drug | GR 127935 | 5.09e-05 | 5 | 52 | 2 | ctd:C090701 | |
| Drug | 22,23-dihydrobufalin | 5.09e-05 | 5 | 52 | 2 | CID000195392 | |
| Drug | 3-acetylstrophanthin | 5.09e-05 | 5 | 52 | 2 | CID003082282 | |
| Drug | thevetin A | 5.09e-05 | 5 | 52 | 2 | CID000441873 | |
| Drug | mecamylamine | 5.12e-05 | 89 | 52 | 4 | CID000004032 | |
| Drug | tropicamide | 5.32e-05 | 32 | 52 | 3 | CID000005593 | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 5.62e-05 | 180 | 52 | 5 | 4776_UP | |
| Drug | Dichloroacetic Acid | 5.68e-05 | 967 | 52 | 10 | ctd:D003999 | |
| Drug | amsonine | 5.77e-05 | 181 | 52 | 5 | CID000002866 | |
| Drug | cytisine | 5.84e-05 | 33 | 52 | 3 | CID000010235 | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; HL60; HT_HG-U133A | 7.63e-05 | 192 | 52 | 5 | 2580_UP | |
| Drug | decamethonium | 7.63e-05 | 6 | 52 | 2 | ctd:C033019 | |
| Drug | oleandrin | 7.63e-05 | 6 | 52 | 2 | ctd:C021065 | |
| Drug | M 129 | 7.63e-05 | 6 | 52 | 2 | CID000192788 | |
| Drug | 2-methoxy-6-methylaminopyridine | 7.63e-05 | 6 | 52 | 2 | CID007019167 | |
| Drug | antileukinate | 7.63e-05 | 6 | 52 | 2 | ctd:C118980 | |
| Drug | Neurotensin (1-6) | 7.63e-05 | 6 | 52 | 2 | CID000137323 | |
| Drug | ETH157 | 7.63e-05 | 6 | 52 | 2 | CID000563154 | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 4743_UP | |
| Drug | Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 5701_UP | |
| Drug | Gi-2 | 8.21e-05 | 195 | 52 | 5 | CID011957432 | |
| Drug | HHSiD | 8.26e-05 | 37 | 52 | 3 | CID000003602 | |
| Drug | ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 2698_UP | |
| Drug | choline | 8.69e-05 | 320 | 52 | 6 | CID000000305 | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 3215_UP | |
| Drug | cobalt(II) chloride hexahydrate; Down 200; 100uM; MCF7; HG-U133A | 8.82e-05 | 198 | 52 | 5 | 383_DN | |
| Drug | epicholesterol | 9.02e-05 | 636 | 52 | 8 | CID000000304 | |
| Drug | cyclosarin | 9.03e-05 | 199 | 52 | 5 | CID000064505 | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 4215_UP | |
| Drug | Cytochalasin D | 9.69e-05 | 39 | 52 | 3 | ctd:D015638 | |
| Drug | methylatropine | 1.05e-04 | 40 | 52 | 3 | CID000005860 | |
| Drug | tridigitoxoside | 1.05e-04 | 40 | 52 | 3 | CID000003061 | |
| Drug | dihydropyrone | 1.07e-04 | 7 | 52 | 2 | CID000010760 | |
| Drug | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine | 1.07e-04 | 7 | 52 | 2 | ctd:C481648 | |
| Drug | dihydrodigitoxigenin | 1.07e-04 | 7 | 52 | 2 | CID000107549 | |
| Drug | 2-(4-isobutylphenyl)propionylmethanesulfonamide | 1.07e-04 | 7 | 52 | 2 | ctd:C490707 | |
| Drug | QX-222 | 1.21e-04 | 42 | 52 | 3 | CID000005014 | |
| Drug | gallamin | 1.30e-04 | 43 | 52 | 3 | CID000067425 | |
| Drug | atropine sulfate | 1.35e-04 | 347 | 52 | 6 | CID000003661 | |
| Drug | dihydro-beta-erythroidine | 1.39e-04 | 44 | 52 | 3 | CID000031762 | |
| Drug | Dimethylphenylpiperazinium Iodide | 1.42e-04 | 8 | 52 | 2 | ctd:D004246 | |
| Drug | glutaconyl-CoA | 1.42e-04 | 8 | 52 | 2 | CID009543049 | |
| Drug | epibatidine | 1.42e-04 | 8 | 52 | 2 | ctd:C082748 | |
| Drug | flerobuterol | 1.42e-04 | 8 | 52 | 2 | CID000071254 | |
| Drug | Alstonine hydrochloride | 1.43e-04 | 116 | 52 | 4 | CID000023039 | |
| Drug | NSC186061 | 1.53e-04 | 118 | 52 | 4 | CID000004163 | |
| Drug | pentobarbital | 1.57e-04 | 224 | 52 | 5 | CID000004737 | |
| Drug | ipratropium bromide | 1.59e-04 | 46 | 52 | 3 | CID000003746 | |
| Drug | pilsicainide | 1.59e-04 | 46 | 52 | 3 | CID000004820 | |
| Drug | phenidone | 1.59e-04 | 46 | 52 | 3 | CID000007090 | |
| Drug | Digoxin | 1.59e-04 | 46 | 52 | 3 | ctd:D004077 | |
| Drug | fluoxetine | 1.61e-04 | 225 | 52 | 5 | CID000003386 | |
| Drug | melantonin | 1.82e-04 | 9 | 52 | 2 | CID000077899 | |
| Drug | BRL 41992 | 1.82e-04 | 9 | 52 | 2 | CID000124249 | |
| Drug | iodide | 2.01e-04 | 534 | 52 | 7 | CID000024841 | |
| Drug | dopamine | 2.02e-04 | 715 | 52 | 8 | CID000000681 | |
| Drug | McN-A-343 | 2.04e-04 | 50 | 52 | 3 | CID000004022 | |
| Drug | chlorisondamine | 2.17e-04 | 51 | 52 | 3 | CID000006243 | |
| Drug | tyramine | 2.22e-04 | 130 | 52 | 4 | CID000005610 | |
| Drug | CM 29-712 | 2.28e-04 | 10 | 52 | 2 | CID000159842 | |
| Drug | PT430 | 2.28e-04 | 10 | 52 | 2 | CID003035882 | |
| Disease | ALTERNATING HEMIPLEGIA OF CHILDHOOD 1 | 3.17e-06 | 2 | 53 | 2 | C3549447 | |
| Disease | alternating hemiplegia of childhood (is_implicated_in) | 3.17e-06 | 2 | 53 | 2 | DOID:0050635 (is_implicated_in) | |
| Disease | Alternating hemiplegia of childhood | 1.89e-05 | 4 | 53 | 2 | C0338488 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.66e-05 | 195 | 53 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 6.61e-05 | 7 | 53 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 9.51e-05 | 49 | 53 | 3 | EFO_0021897 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.74e-04 | 60 | 53 | 3 | EFO_0022237 | |
| Disease | nervous system disease (implicated_via_orthology) | 2.07e-04 | 12 | 53 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.13e-04 | 163 | 53 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 38:6 measurement | 3.74e-04 | 16 | 53 | 2 | EFO_0010388 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.74e-04 | 16 | 53 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | X-24309 measurement | 5.89e-04 | 20 | 53 | 2 | EFO_0800872 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 6.61e-04 | 220 | 53 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 7.19e-04 | 225 | 53 | 4 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.19e-04 | 225 | 53 | 4 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio | 7.43e-04 | 227 | 53 | 4 | EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 7.68e-04 | 229 | 53 | 4 | EFO_0004639, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 9.00e-04 | 239 | 53 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 9.52e-04 | 107 | 53 | 3 | EFO_0004614, EFO_0004615 | |
| Disease | cholesteryl ester measurement | 1.18e-03 | 257 | 53 | 4 | EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.30e-03 | 264 | 53 | 4 | EFO_0008317, EFO_0020944 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.56e-03 | 127 | 53 | 3 | EFO_0008595, EFO_0020947 | |
| Disease | Bipolar Disorder | 1.64e-03 | 477 | 53 | 5 | C0005586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKFLCVKLVVFVSFW | 246 | Q9NVA4 | |
| FWNLVFLLTVSCVKG | 46 | Q7Z407 | |
| WVFTLVCILGTAGLF | 481 | P32297 | |
| ICIGFQSLGFFWVKQ | 1016 | Q9H7F0 | |
| AKTLGIVVGCFVLCW | 271 | P35348 | |
| CIFIIGLFVNITALW | 31 | Q14330 | |
| WSIFLIGTKIGLFLQ | 6 | Q9NZU0 | |
| VVFLLTLFWGCLGFT | 331 | Q8N139 | |
| IRKYILKFCIVGWGV | 731 | Q8IZP9 | |
| WLFIIVCFLGTIGLF | 506 | Q15822 | |
| VLWIFGFLVCMGVIL | 296 | P98198 | |
| VQSSGVLIIFWFLCV | 131 | O15438 | |
| LGWICFCFSFIIGVL | 136 | P54849 | |
| VCVRLVGTAWFFGLI | 141 | Q8NGE0 | |
| SWVFLVAIIKGVQCQ | 6 | P01762 | |
| LSWVFLVAIFKGVQC | 6 | A0A075B6Q5 | |
| GLLSFIVWKKTFIQG | 261 | O95665 | |
| KWIHCFEGVTCIIFI | 206 | P11488 | |
| SWVFLVGILKGVQCE | 6 | A0A0C4DH36 | |
| KTLVLVGCFTVFWTV | 666 | Q16549 | |
| LGLIILLLWKCGFFK | 1006 | P26006 | |
| GIQTGLTWVALIFCI | 21 | Q9H343 | |
| GWIFGTFLCKVVSLL | 111 | P25025 | |
| FWKVGLISGTVFVIL | 61 | Q8IZ57 | |
| VIQGCFWLFGTVILK | 341 | Q2PZI1 | |
| TIVGFIWLLKVNGCR | 256 | Q8TD46 | |
| VSFTLIVGIFVLQKW | 506 | Q8WTR4 | |
| KLINICIWVLASGVG | 166 | P41143 | |
| CGFGLSLIKWILIVR | 266 | Q9NV92 | |
| EWVKFCRQLFGGFSI | 86 | P50993 | |
| LGKKWRQIIFGICFF | 3681 | Q9C0G6 | |
| ILCFLIFLGKTWGQE | 6 | P01031 | |
| WLFGRIGCKLIPFIQ | 106 | P30550 | |
| NGWIFGTFLCKVVSL | 101 | P25024 | |
| KILGIILGAFIICWL | 301 | P28221 | |
| AVTITILLGVFIFCW | 241 | P41968 | |
| KFCRQLFGGFSILLW | 81 | P13637 | |
| FAILLFWGQFGIKTL | 151 | Q08722 | |
| VCGFIHLVIEGWFVL | 71 | Q15125 | |
| SWVFLAGILKGVQCE | 6 | A0A0C4DH30 | |
| GSLIFCFGIWILIDK | 26 | P11049 | |
| LGFVKVLQWVFAIFA | 26 | P08247 | |
| EHAKGVCIFVWILVF | 146 | P32249 | |
| SGKVWVGIGLCIALF | 156 | Q96J65 | |
| AQLKKIFWGVAVVLC | 61 | Q8IY50 | |
| GLVVFLLTVFWGCLG | 331 | O94911 | |
| SVQTGIWVFLFKLLI | 2061 | Q63HN8 | |
| WAKLVVGSVAIVCFA | 21 | Q5T4D3 | |
| VSWIIFLKIGAGCQV | 41 | Q8N2B8 | |
| GVFLFFVLVGICWCQ | 196 | Q71H61 | |
| TIFSKGGLVLWCFQG | 6 | P08240 | |
| AKTLGIVIGVFLLCW | 261 | Q9P1P5 | |
| WVIQCLIVGERIGFK | 1946 | Q12888 | |
| VENNWFKCFIGLVTL | 931 | Q01118 | |
| VWFGLAKLGCVVAFL | 121 | Q9Y2P4 | |
| WAVKMVTCFIIGLLF | 326 | Q9UBN4 | |
| IGVLWAIFTICFAIV | 36 | Q86UP9 |